Get all premium features to the best stock analysis tool

Nutrien is mispriced as the market overweights European sustainability policy, ignoring surging synthetic fertilizer demand in emerging markets. NTR's integrated model, record 2025 EBITDA of $6.05B, and 14x forward P/E position it for structural demand growth, not decline. Key catalysts include Q1 2026 earnings, potash price stabilization, and continued retail expansion in Brazil and other developing regions.

NTR beat Q1 earnings estimates as record potash volumes, stronger pricing and Retail demand lifted earnings and sales sharply year over year.

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Mark Thompson, Nutrien's Executive Vice President and Chief Financial Officer, will be speaking at the BMO Farm to Market Conference on Wednesday, May 13 at 8:45am EDT. The fireside chat will be video cast and available on the Company's website at https://www.nutrien.com/investors/events. About Nutrien Nutrien is a leading global provider of crop inputs and services. We operate a world-class netw.

Nutrien Ltd. (NTR:CA) Q1 2026 Earnings Call Transcript

Nutrien (NTR) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.11 per share a year ago.

Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today the results of its annual meeting of shareholders held on May 6, 2026 (the “Meeting”). A total of 366,120,629 common shares, representing 76.09% of common shares outstanding, were represented at the Meeting. Results of the matters voted on at the Meeting are set out below. Election of Directors Nutrien's 12 director nominees were elected: Votes For (percent) Votes Against (percent) Christopher M. Burley 9.